MARKET

MIRA

MIRA

Mira Pharma
NASDAQ
1.480
-0.010
-0.67%
After Hours: 1.470 -0.01 -0.68% 19:57 01/09 EST
OPEN
1.500
PREV CLOSE
1.490
HIGH
1.540
LOW
1.480
VOLUME
148.28K
TURNOVER
--
52 WEEK HIGH
2.450
52 WEEK LOW
0.7300
MARKET CAP
61.98M
P/E (TTM)
-0.9737
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MIRA last week (1229-0102)?
Weekly Report · 6d ago
Weekly Report: what happened at MIRA last week (1222-1226)?
Weekly Report · 12/29/2025 09:36
Mira Pharmaceuticals Awards CEO Erez Aminov New Incentive Compensation Package
Reuters · 12/22/2025 11:03
Weekly Report: what happened at MIRA last week (1215-1219)?
Weekly Report · 12/22/2025 09:36
Weekly Report: what happened at MIRA last week (1208-1212)?
Weekly Report · 12/15/2025 09:39
Weekly Report: what happened at MIRA last week (1201-1205)?
Weekly Report · 12/08/2025 09:39
MIRA Pharmaceuticals Expands Stock Offering by $15M
TipRanks · 12/05/2025 22:50
Weekly Report: what happened at MIRA last week (1124-1128)?
Weekly Report · 12/01/2025 09:37
More
About MIRA
MIRA Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of therapeutics for neurologic, neuropsychiatric, and metabolic disorders. The Company's pipeline includes oral drug candidates designed to address significant unmet medical needs in neuropathic pain, inflammatory pain, obesity, addiction, anxiety, and cognitive decline. It holds exclusive license rights in the United States, Canada and Mexico for Ketamir-2 and MIRA-55, two novel drug candidates designed to address unmet medical needs in neuropathic and inflammatory pain, as well as neuropsychiatric and neurocognitive disorders. Its pipeline also includes SKNY-1, a next-generation oral therapy candidate for obesity and smoking cessation. Ketamir-2 is a patent-pending oral ketamine analog evaluated for the treatment of diabetic neuropathy and is in an ongoing Phase I clinical trial.

Webull offers Mira Pharmaceuticals Inc stock information, including NASDAQ: MIRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRA stock methods without spending real money on the virtual paper trading platform.